Press release
IGC Pharma's (NYSE: IGC) CEO Appears on Bloomberg TV Discussing Alzheimer's Fast-Acting IGC-AD1 Pharmaceutical Therapeutic - More Stocks Inside
The company recently reported that enrollment in its Phase 2 CALMA clinical trial has reached approximately 80% of its target, marking a significant milestone as IGC advances one of its most closely watched Alzheimer's therapeutics programs. The company has also expanded its clinical site network and strengthened its intellectual property portfolio, including new patents tied to its proprietary AI-powered drug discovery platform and IGC-AD1. Listen To Full Interview Now! [https://www.youtube.com/watch?v=rNLeeu3v6S4&t=92s]
Alongside IGC Pharma (NYSE: IGC), investors are watching Volato Group, Inc. (NYSE: SOAR), Abits Group Inc. (Nasdaq: ABTS), HUB Cyber Security Ltd. (Nasdaq: HUBC), Hitek Global Inc. (Nasdaq: HKIT), and Kartoon Studios (NYSE: TOON) as these smallcap stocks under $1, high-volume momentum stocks remain active in early trading.
Beyond Alzheimer's agitation, IGC Pharma is developing additional programs targeting amyloid plaques, neurodegenerative disease, cognitive decline, precision medicine, and neuroscience innovation, positioning the company at the intersection of artificial intelligence and biotechnology.
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.
Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=igc-pharmas-nyse-igc-ceo-appears-on-bloomberg-tv-discussing-alzheimers-fastacting-igcad1-pharmaceutical-therapeutic-more-stocks-inside]
Country: United States
Website: http://www.thestreetreports.com
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release IGC Pharma's (NYSE: IGC) CEO Appears on Bloomberg TV Discussing Alzheimer's Fast-Acting IGC-AD1 Pharmaceutical Therapeutic - More Stocks Inside here
News-ID: 4534327 • Views: …
More Releases from ABNewswire
Sphere 3D Corp. (NASDAQ: ANY) Surges on Acquisition AI Infrastructure Platform A …
Sphere 3D Corp. (NASDAQ: ANY) surged more than 100% in early trading, with over $100 million in shares traded, after announcing the completion of its merger with Cathedra Bitcoin, creating a scaled digital infrastructure platform with 53 megawatts (MW) of operating power capacity and a 100MW+ expansion pipeline targeting AI infrastructure, data centers, high-performance computing (HPC), and digital asset markets.
The transaction transforms Sphere 3D into a larger AI infrastructure and…
Food Allergy Market Expected to Experience Accelerated Growth and Market Evoluti …
The Key Food Allergy Companies in the market include - Novartis, Roche, ARS Pharmaceuticals, ALK Abello, Alfresa Pharma, Stallergenes Greer, DBV Technologies, Aravax, Aimmune Therapeutics, Inc., Novartis Pharmaceuticals, DBV Technologies, Intrommune Therapeutics, Xencor, Vedanta Biosciences, Alladapt Immunotherapeutics, Aravax, Regeneron, DBV Technologies, Novartis AG, Camallergy, Genentech, GI Innovation, and others.
DelveInsight's "Food Allergy Market Insights, Epidemiology, and Market Forecast-2036 report offers an in-depth understanding of the Food Allergy, historical and forecasted epidemiology…
Alport Syndrome Market Trends, Innovation, and Future Growth Outlook to 2036 - D …
The Key Alport Syndrome Companies in the market include - Eloxx Pharmaceuticals, Inc., Biogen, River 3 Renal Corp., Travere Therapeutics, Inc. , Chinook Therapeutics U.S., Inc., Bayer, and others.
DelveInsight's "Alport Syndrome Market Insights, Epidemiology, and Market Forecast-2036 report offers an in-depth understanding of the Alport Syndrome, historical and forecasted epidemiology as well as the Alport Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom…
Excessive Daytime Sleepiness Market Emerging as a High-Growth Healthcare Investm …
The Key Excessive Daytime Sleepiness Companies in the market include - Avadel Pharmaceuticals, Axsome Therapeutics, Theranexus, Suven LifeSciences, NLS Pharma, XWPharma, Balance Therapeutics, Takeda Pharmaceuticals, Benevolent AI Bio, Avadel Pharmaceuticals, and others.
DelveInsight's "Excessive Daytime Sleepiness Market Insights, Epidemiology, and Market Forecast-2036 report offers an in-depth understanding of the Excessive Daytime Sleepiness, historical and forecasted epidemiology as well as the Excessive Daytime Sleepiness market trends in the United States, EU4 (Germany,…
More Releases for IGC
Alzheimer's AI Biotech IGC Pharma, Inc. (NYSE: IGC) Stock in Focus - More Stocks …
IGC Pharma, Inc. (NYSE: IGC) a clinical-stage biotechnology company developing AI-powered Alzheimer's disease therapies, is gaining investor attention after reporting Q1 2026 financial results and continued progress in its ongoing Phase 2 CALMA clinical trial evaluating IGC-AD1 for agitation associated with Alzheimer's dementia.
The company reported that patient enrollment in the CALMA trial recently reached approximately 80% completion, advancing toward its target enrollment of 146 patients. IGC Pharma also expanded its…
IGC Loyalty Turns Poland Trade Mission into European Growth Breakthrough
Sydney, Australia / Poland - 29th March 2026
What began as a short-term trade visit has rapidly evolved into a defining expansion moment for IGC Loyalty, following an extended and highly productive presence in Poland.
Led by CEO Simon Church, the trip originally scheduled for just two weeks was extended to over two and a half months as demand surged from enterprise partners across multiple industries.
Throughout the mission, IGC Loyalty engaged in…
Hex Bolts Market Size, Dynamics 2031 by Major Companies- Acument Global Technolo …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲: According to Verified Market Reports analysis, the global Hex Bolts Market size was valued at USD 8.211 Billion in 2023 and is expected to reach USD 11.49 Billion by the end of 2031 with a CAGR of 4.9% During the Forecast Period 2023-2031.
The hex bolts market presents significant opportunities driven by the widespread use of hex bolts across various industries, including construction, automotive, manufacturing, and infrastructure development.…
Global Calcium Pyrophosphate (CAS 7790-76-3) Market Research Report 2019-2025 || …
This research report titled “Global (United States, European Union and China) Calcium Pyrophosphate (CAS 7790-76-3) Market Research Report 2019-2025” has been added to the wide online database managed by Market Research Hub (MRH). The study discusses the prime market growth factors along with future projections expected to impact the Calcium Pyrophosphate (CAS 7790-76-3) Market during the period between 2019 and 2025. The concerned sector is analyzed based on different market…
Commercial Greenhouse Equipments Market Outlook, Challenges, Technology Demand, …
The commercial greenhouse is a structure made chiefly of roof and walls by using a transparent material such as glass, where plant requiring climatic conditions are developed. The size is varied from a small shed to industrial-sized buildings. Majority of these greenhouses have high technology production facilities for flowers and vegetables. These are filled with equipment such as heating, cooling, screening installations, and lighting among others.
Get Sample Copy of this…
Switchable Glass Market Outlook to 2023 by Key Players Glass Apps, IGC, SMARTGLA …
A report added to the rich database of Qurate Business Intelligence, titled “World Switchable Glass Market Research Report 2023 (Covering USA, Europe, China, Japan, India and etc)”, provides a 360-degree overview of the Global market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market…
